Veeva price target raised to $240 from $220 at Barclays

Barclays raised the firm’s price target on Veeva to $240 from $220 and keeps an Overweight rating on the shares ahead of the earnings report on February 29. The analyst is modeling 12% billings growth for Q4 and notes some large deals slipped to fiscal 2025, which the firm thinks “offers some de-risking.”